In our continuing effort to part the clouds of our crystal ball, here is another industry veteran to share his insights into the landscape of dental M&A. Mick Janness is the CEO of Oakpoint, a PE-backed Mid-Atlantic DSO that has seen tremendous growth over the last few years. This isn’t Mick’s first rodeo, and he drops valuable pearls of wisdom frequently in this episode, so have your pad and pen handy!

Join us for an exclusive MA&A MasterClass opportunity this May 19/20th in Charlotte, NC.

Learn more or register today: https://bit.ly/MasterClassMAandA

We all know that the valuation a buyer places on your business comprises many different factors, but one of the primary ones is how they assess your inherent risks. What are the main risks they look at? And what can you do to control those? Tune in because I cover all of it along with a new addition to the Polaris Team – Miss Rylee Hamblin!

Brian Colao of the Dykema Law Group and Steve Mizrach of the accounting firm Dorfman, Mizrach & Thaler join me on the show today to talk through the year that was 2021, where we are in 2022 and where we’re going in 2023. We go from big picture to even more tactical considerations around LOIs, QOEs and a lot of other acronyms I don’t understand. This episode is a tour de force!

Brian Colao: [email protected]

Dykema Law Group: https://www.dykema.com/people/brian-a-colao.html

Steve Mizrach: [email protected]

Dorfman, Mizrach & Thaler: https://www.dsocpas.com/

Selling a business is a lengthy and emotionally draining process. What if you got to the end and it all fell apart? There are quite a few things you can do ahead of time to minimize your chances for failure. Diwakar helps me unpack all of them. What about acquiring practices yourself? We teach you all about it in our next MasterClass on April 21&22! That and Animal Farm – all on today’s show!

Register for our upcoming MA&A MasterClass here: https://bit.ly/3LrqfKU

2021 was the largest year on record in terms of global M&A activity and the dental industry was part of it. If you’re contemplating going to market in 2022 or 2023, here’s your primer on what you need to know. Diwakar shares all of his insights in rapid fashion! What’s the difference between a Summit and a MasterClass?! I unpack that as well.

The Dental M&A markets are still white hot as we roll into 2022, which has many of you “curious” about what an exit might mean. Before you go down the road of a marketed sales process, here are THE three things you need clarity on. Tune in to learn more!

Dr. Vivek Solanki joins me on the show today to tell his amazing story from traveling Periodontist to Partner Buy-In to Practice sale – all in 16 months! He unpacks all aspects of the impact of COVID to how he approached clinical and operational improvements to deciding to go through a sell-side process and then to our guidance on his outcome. This episode is an absolute tour de force and I’m exhausted from just hosting it!

“Dr. Vivek Solanki was born in Jacksonville, Florida and attended the University of Florida for undergrad, then Howard University College of Dentistry (2007-2011). He performed a two-year general practice residency at Einstein Medical Center Philadelphia (2011-2013) and completed his Periodontics specialty in 2016 at the Veterans Affairs Hospital in West Los Angeles.”

This episode ought to give you the guidance you need to think through all aspects of funding. Today Diwakar and I discuss trends at an enterprise level around capital use and capital sourcing. We also compare and contrast the following: using an equity partner vs debt capital for growth; the difference in asset-based lending vs cash flow-based lending; Lower Middle Market vs Middle Market covenants & ratios; and traditional bank lenders vs non-bank lenders. That and the “Gates of Fire” on today’s episode!

Sign Up for our De Novo MasterClasse here:

https://bit.ly/MasterClass_DeNovo

In today’s episode, Diwakar and I clarify a few misconceptions around the topics of Free Cash Flow vs EBITDA vs Distributions, and we share some fundamental guidance on three ways you should be allocating your cash.

Sign Up for our De Novo MasterClass here:

https://bit.ly/MasterClass_DeNovo

If you’re going to build a group at any rate of speed, you’re more than likely going to outgrow your current retail lender. Diwakar and I compare and contrast banking solutions: Retail vs. Lower Middle Market vs. Middle Market. We also dive deep into the critical concepts of Guidance Line, Credit Facility, and Debt Recapitalization. With rates surely going up, now is the time to reevaluate your banking relationship!